12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

GMS-Classifier1 diagnostic data

Data from an observational study of 120 patients showed that Glycominds' gMS-Classifier1 had 71% sensitivity and 75% specificity for identifying patients with MS Severity Score (MSSS) >=5, with positive and negative predictive values of 28% and 88%, respectively. Patients...

Read the full 171 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >